Prof. Mike Dennis is recognised as a key opinion leader in myeloid malignancy, with established expertise in acute myeloid leukaemia (AML). After graduating from the University of Dundee in 1991, he trained as a physician in Liverpool before moving to Australia to specialise in haematology. Upon returning to the UK, Prof. Dennis joined The Christie for further haematology training in Liverpool. He became a Consultant Haematologist in 2004, where he works on the haematology and transplant unit. Prof. Dennis is an active researcher with the National Cancer Research Network's AML and myelodysplasia working groups and is a member of several professional groups, including the European Group for Blood and Marrow Transplantation (EBMT), the Royal College of Physicians, the Royal College of Pathologists, European Haematology Association, American Society for Hematology, and the British Society for Haematology. His areas of expertise include leukaemia (AML, CML, myelodysplasia, and myeloproliferative disorders), haematology, and stem cell and bone marrow transplantation.